Closed 34 of 38 events
Lifecycle stage Response Published
1,016 days in stage

UK Medical Devices Regulation Reform

The Medicines and Healthcare products Regulatory Agency (MHRA) is reforming UK medical devices regulation to align with post-Brexit frameworks and address emerging technologies including AI-enabled devices. The reform covers CE marking recognition, in vitro diagnostics, point-of-care testing, registration requirements, and economic operator responsibilities. This active policy aims to modernise the regulatory pathway while maintaining safety and efficacy standards.


Showing 34 of 38 signals
Family 1
Signal
Year
Body
Role
Clear all

2023

2 events
25 Jan 2023 | Consultation outcome Medicines and Healthcare products Regulatory Agency linked

Point of Care Consultation — outcome published

We’d value your views to help shape the introduction of a new regulatory framework for products supplied at the point of care.

2022

28 events
26 Jun 2022 | Consultation outcome Medicines and Healthcare products Regulatory Agency linked

Consultation on the future regulation of medical devices in the United Kingdom — outcome published

We're looking for your views on how medical devices will be regulated across the United Kingdom (UK) in the future.

View document · GOV.UK · Cover Page (1pp)
+72 more
Ministerial Foreword Ministerial Foreword (1pp) Executive summary Executive Summary (2pp) Introduction Introduction (2pp) Information for respondents Information for Respondents (2pp) Overview of contents Overview of Contents (7pp) Medicines and Medical Devices Act 2021 Assessment Medicines and Medical Devices Act 2021 Assessment (5pp) Data Protection and Privacy Information Data Protection and Privacy Information (2pp) Devices Regulation - Background Devices Regulation - Background (2pp) Chapter 1: Scope of the Regulations Chapter 1: Scope of the Regulations (7pp) Chapter 2: Classification Chapter 2: Classification (3pp) Chapter 3: Economic Operators Chapter 3: Economic Operators (17pp) Chapter 4: Registration and UDI Chapter 4: Registration and UDI (13pp) Chapter 5: Approved Bodies Chapter 5: Approved Bodies (7pp) Chapter 6: Conformity Assessment Chapter 6: Conformity Assessment (8pp) Chapter 7: Clinical Investigation / Performance Studies Chapter 7: Clinical Investigation / Performance Studies (40pp) Chapter 8: Post-market Surveillance and Vigilance Chapter 8: Post-market Surveillance and Vigilance (9pp) Chapter 9: In vitro Diagnostic Medical Devices Chapter 9: In vitro Diagnostic Medical Devices (5pp) Chapter 10: Software as a Medical Device Chapter 10: Software as a Medical Device (6pp) Chapter 11: Implantable Devices Chapter 11: Implantable Devices (6pp) Chapter 12: Other Product-Specific Changes Chapter 12: Other Product-Specific Changes (7pp) Chapter 13: Environmental sustainability and public health … Chapter 13: Environmental sustainability and public health … (3pp) Chapter 14: Routes to market Chapter 14: Routes to market (4pp) Chapter 15: Transitional Arrangements Chapter 15: Transitional Arrangements (3pp) Chapter 16: Feedback Chapter 16: Feedback (1pp) Chapter 17: Questions for members of the general public Chapter 17: Questions for members of the general public (12pp) Appendix (5pp) Glossary (11pp) Government response to consultation on the future regulatio… (155pp) Ministerial Foreword Executive Summary Assessment of the requirements under the Medicine and Medic… Chapter 1 - Scope of the Regulations Chapter 2 - Classification Chapter 3 - Economic Operators Chapter 4 - Registration and UDI Chapter 5 - Approved Bodies Chapter 6 - Conformity Assessments Chapter 7 - Clinical Investigation and Performance Studies Chapter 8 - Post-market Surveillance, Vigilance, Market Sur… Chapter 9 - In vitro Diagnostic Medical Devices Chapter 10 - Software as a Medical Device Chapter 11 - Implantable Devices Chapter 12 - Other Product Specific Changes Chapter 13 - Environmental Sustainability and Public Health… Chapter 14 - Alternative Routes to Market Chapter 15 - Transitional Arrangements Chapter 16 - Feedback

2021

4 events
25 Nov 2021 | Consultation outcome Medicines and Healthcare products Regulatory Agency linked

Consultation on the future regulation of medical devices in the United Kingdom — consultation closed

We're looking for your views on how medical devices will be regulated across the United Kingdom (UK) in the future.

View document · GOV.UK · Cover Page (1pp)
+72 more
Ministerial Foreword Ministerial Foreword (1pp) Executive summary Executive Summary (2pp) Introduction Introduction (2pp) Information for respondents Information for Respondents (2pp) Overview of contents Overview of Contents (7pp) Medicines and Medical Devices Act 2021 Assessment Medicines and Medical Devices Act 2021 Assessment (5pp) Data Protection and Privacy Information Data Protection and Privacy Information (2pp) Devices Regulation - Background Devices Regulation - Background (2pp) Chapter 1: Scope of the Regulations Chapter 1: Scope of the Regulations (7pp) Chapter 2: Classification Chapter 2: Classification (3pp) Chapter 3: Economic Operators Chapter 3: Economic Operators (17pp) Chapter 4: Registration and UDI Chapter 4: Registration and UDI (13pp) Chapter 5: Approved Bodies Chapter 5: Approved Bodies (7pp) Chapter 6: Conformity Assessment Chapter 6: Conformity Assessment (8pp) Chapter 7: Clinical Investigation / Performance Studies Chapter 7: Clinical Investigation / Performance Studies (40pp) Chapter 8: Post-market Surveillance and Vigilance Chapter 8: Post-market Surveillance and Vigilance (9pp) Chapter 9: In vitro Diagnostic Medical Devices Chapter 9: In vitro Diagnostic Medical Devices (5pp) Chapter 10: Software as a Medical Device Chapter 10: Software as a Medical Device (6pp) Chapter 11: Implantable Devices Chapter 11: Implantable Devices (6pp) Chapter 12: Other Product-Specific Changes Chapter 12: Other Product-Specific Changes (7pp) Chapter 13: Environmental sustainability and public health … Chapter 13: Environmental sustainability and public health … (3pp) Chapter 14: Routes to market Chapter 14: Routes to market (4pp) Chapter 15: Transitional Arrangements Chapter 15: Transitional Arrangements (3pp) Chapter 16: Feedback Chapter 16: Feedback (1pp) Chapter 17: Questions for members of the general public Chapter 17: Questions for members of the general public (12pp) Appendix (5pp) Glossary (11pp) Government response to consultation on the future regulatio… (155pp) Ministerial Foreword Executive Summary Assessment of the requirements under the Medicine and Medic… Chapter 1 - Scope of the Regulations Chapter 2 - Classification Chapter 3 - Economic Operators Chapter 4 - Registration and UDI Chapter 5 - Approved Bodies Chapter 6 - Conformity Assessments Chapter 7 - Clinical Investigation and Performance Studies Chapter 8 - Post-market Surveillance, Vigilance, Market Sur… Chapter 9 - In vitro Diagnostic Medical Devices Chapter 10 - Software as a Medical Device Chapter 11 - Implantable Devices Chapter 12 - Other Product Specific Changes Chapter 13 - Environmental Sustainability and Public Health… Chapter 14 - Alternative Routes to Market Chapter 15 - Transitional Arrangements Chapter 16 - Feedback
23 Sep 2021 | Consultation outcome Medicines and Healthcare products Regulatory Agency linked

Point of Care Consultation — consultation closed

We’d value your views to help shape the introduction of a new regulatory framework for products supplied at the point of care.

16 Sep 2021 | Consultation outcome Medicines and Healthcare products Regulatory Agency linked

Consultation on the future regulation of medical devices in the United Kingdom — consultation opened

We're looking for your views on how medical devices will be regulated across the United Kingdom (UK) in the future.

View document · GOV.UK · Cover Page (1pp)
+72 more
Ministerial Foreword Ministerial Foreword (1pp) Executive summary Executive Summary (2pp) Introduction Introduction (2pp) Information for respondents Information for Respondents (2pp) Overview of contents Overview of Contents (7pp) Medicines and Medical Devices Act 2021 Assessment Medicines and Medical Devices Act 2021 Assessment (5pp) Data Protection and Privacy Information Data Protection and Privacy Information (2pp) Devices Regulation - Background Devices Regulation - Background (2pp) Chapter 1: Scope of the Regulations Chapter 1: Scope of the Regulations (7pp) Chapter 2: Classification Chapter 2: Classification (3pp) Chapter 3: Economic Operators Chapter 3: Economic Operators (17pp) Chapter 4: Registration and UDI Chapter 4: Registration and UDI (13pp) Chapter 5: Approved Bodies Chapter 5: Approved Bodies (7pp) Chapter 6: Conformity Assessment Chapter 6: Conformity Assessment (8pp) Chapter 7: Clinical Investigation / Performance Studies Chapter 7: Clinical Investigation / Performance Studies (40pp) Chapter 8: Post-market Surveillance and Vigilance Chapter 8: Post-market Surveillance and Vigilance (9pp) Chapter 9: In vitro Diagnostic Medical Devices Chapter 9: In vitro Diagnostic Medical Devices (5pp) Chapter 10: Software as a Medical Device Chapter 10: Software as a Medical Device (6pp) Chapter 11: Implantable Devices Chapter 11: Implantable Devices (6pp) Chapter 12: Other Product-Specific Changes Chapter 12: Other Product-Specific Changes (7pp) Chapter 13: Environmental sustainability and public health … Chapter 13: Environmental sustainability and public health … (3pp) Chapter 14: Routes to market Chapter 14: Routes to market (4pp) Chapter 15: Transitional Arrangements Chapter 15: Transitional Arrangements (3pp) Chapter 16: Feedback Chapter 16: Feedback (1pp) Chapter 17: Questions for members of the general public Chapter 17: Questions for members of the general public (12pp) Appendix (5pp) Glossary (11pp) Government response to consultation on the future regulatio… (155pp) Ministerial Foreword Executive Summary Assessment of the requirements under the Medicine and Medic… Chapter 1 - Scope of the Regulations Chapter 2 - Classification Chapter 3 - Economic Operators Chapter 4 - Registration and UDI Chapter 5 - Approved Bodies Chapter 6 - Conformity Assessments Chapter 7 - Clinical Investigation and Performance Studies Chapter 8 - Post-market Surveillance, Vigilance, Market Sur… Chapter 9 - In vitro Diagnostic Medical Devices Chapter 10 - Software as a Medical Device Chapter 11 - Implantable Devices Chapter 12 - Other Product Specific Changes Chapter 13 - Environmental Sustainability and Public Health… Chapter 14 - Alternative Routes to Market Chapter 15 - Transitional Arrangements Chapter 16 - Feedback
12 Aug 2021 | Consultation outcome Medicines and Healthcare products Regulatory Agency linked

Point of Care Consultation — consultation opened

We’d value your views to help shape the introduction of a new regulatory framework for products supplied at the point of care.